tiprankstipranks
Praxis Precision announces U.S. FDA granted RPDD for relutrigine
PremiumThe FlyPraxis Precision announces U.S. FDA granted RPDD for relutrigine
1M ago
Praxis Precision management to meet with Oppenheimer
Premium
The Fly
Praxis Precision management to meet with Oppenheimer
2M ago
GeneDx expands access to exome testing for pediatric epilepsy patients
Premium
The Fly
GeneDx expands access to exome testing for pediatric epilepsy patients
2M ago
Praxis Precision Advances CNS Disorder Therapies
PremiumCompany AnnouncementsPraxis Precision Advances CNS Disorder Therapies
3M ago
Praxis Precision reports Q3 EPS ($2.75), consensus ($1.99)
Premium
The Fly
Praxis Precision reports Q3 EPS ($2.75), consensus ($1.99)
3M ago
Praxis Precision price target raised to $163 from $143 at Oppenheimer
Premium
The Fly
Praxis Precision price target raised to $163 from $143 at Oppenheimer
3M ago
Praxis Precision management to meet with Piper Sandler
PremiumThe FlyPraxis Precision management to meet with Piper Sandler
4M ago
Praxis Precision present poster on ulixacaltamide Essential3 program
Premium
The Fly
Praxis Precision present poster on ulixacaltamide Essential3 program
4M ago
Praxis Precision price target raised to $151 from $145 at Needham
Premium
The Fly
Praxis Precision price target raised to $151 from $145 at Needham
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100